Silverfin false false 31/03/2026 01/10/2024 31/03/2026 C Cairns 23/10/2025 I Cairns 21/09/2018 27 July 2026 The principal activity of the Company during the financial period continued to be that of specialist medical practice activities. SC608843 2026-03-31 SC608843 bus:Director1 2026-03-31 SC608843 bus:Director2 2026-03-31 SC608843 2024-09-30 SC608843 core:CurrentFinancialInstruments 2026-03-31 SC608843 core:CurrentFinancialInstruments 2024-09-30 SC608843 core:Non-currentFinancialInstruments 2026-03-31 SC608843 core:Non-currentFinancialInstruments 2024-09-30 SC608843 core:ShareCapital 2026-03-31 SC608843 core:ShareCapital 2024-09-30 SC608843 core:RetainedEarningsAccumulatedLosses 2026-03-31 SC608843 core:RetainedEarningsAccumulatedLosses 2024-09-30 SC608843 core:LeaseholdImprovements 2024-09-30 SC608843 core:FurnitureFittings 2024-09-30 SC608843 core:LeaseholdImprovements 2026-03-31 SC608843 core:FurnitureFittings 2026-03-31 SC608843 core:CostValuation 2024-09-30 SC608843 core:AdditionsToInvestments 2026-03-31 SC608843 core:CostValuation 2026-03-31 SC608843 bus:OrdinaryShareClass1 2026-03-31 SC608843 2024-10-01 2026-03-31 SC608843 bus:FilletedAccounts 2024-10-01 2026-03-31 SC608843 bus:SmallEntities 2024-10-01 2026-03-31 SC608843 bus:AuditExemptWithAccountantsReport 2024-10-01 2026-03-31 SC608843 bus:PrivateLimitedCompanyLtd 2024-10-01 2026-03-31 SC608843 bus:Director1 2024-10-01 2026-03-31 SC608843 bus:Director2 2024-10-01 2026-03-31 SC608843 1 2024-10-01 2026-03-31 SC608843 core:LeaseholdImprovements core:TopRangeValue 2024-10-01 2026-03-31 SC608843 core:FurnitureFittings core:TopRangeValue 2024-10-01 2026-03-31 SC608843 2023-10-01 2024-09-30 SC608843 core:LeaseholdImprovements 2024-10-01 2026-03-31 SC608843 core:FurnitureFittings 2024-10-01 2026-03-31 SC608843 core:CurrentFinancialInstruments 2024-10-01 2026-03-31 SC608843 core:Non-currentFinancialInstruments 2024-10-01 2026-03-31 SC608843 bus:OrdinaryShareClass1 2024-10-01 2026-03-31 SC608843 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC608843 (Scotland)

# CAIRNS HEALTHCARE LTD
(Formerly Aurum Aesthetics Ltd)

### UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 01 OCTOBER 2024 TO 31 MARCH 2026
PAGES FOR FILING WITH THE REGISTRAR

CAIRNS HEALTHCARE LTD

## UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 01 OCTOBER 2024 TO 31 MARCH 2026

Contents

CAIRNS HEALTHCARE LTD

## BALANCE SHEET

AS AT 31 MARCH 2026
CAIRNS HEALTHCARE LTD

## BALANCE SHEET (continued)

AS AT 31 MARCH 2026

| Note | 31.03.2026 |  | 30.09.2024
|  | £ |  | £
Fixed assets |  |  |  |
Investment property | 4 | 180,000 |  | 0
Investments | 5 | 800,000 |  | 0
|  | 980,000 |  | 0
Current assets |  |  |  |
Debtors | 6 | 999 |  | 0
Cash at bank and in hand |  | 12,696 |  | 11,593
|  | 13,695 |  | 11,593
Creditors: amounts falling due within one year | 7 | ( 128,508) |  | 0
Net current (liabilities)/assets |  | (114,813) |  | 11,593
Total assets less current liabilities |  | 865,187 |  | 11,593
Creditors: amounts falling due after more than one year | 8 | ( 851,814) |  | 0
Net assets |  | 13,373 |  | 11,593
Capital and reserves |  |  |  |
Called-up share capital | 9 | 100 |  | 11
Profit and loss account |  | 13,273 |  | 11,582
Total shareholders' funds |  | 13,373 |  | 11,593

For the financial period ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Cairns Healthcare Ltd (registered number: SC608843) were approved and authorised for issue by the Board of Directors on 27 July 2026. They were signed on its behalf by:

I Cairns Director |

CAIRNS HEALTHCARE LTD

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 01 OCTOBER 2024 TO 31 MARCH 2026
CAIRNS HEALTHCARE LTD

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 01 OCTOBER 2024 TO 31 MARCH 2026

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period and to the preceding financial year, unless otherwise stated.

##### General information and basis of accounting

Cairns Healthcare Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is 38 Park Terrace, Aberuthven, Auchterarder, PH3 1HU, Scotland, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

##### Reporting period length

Reporting period length covers an extended period of 18 months from 1 October 2024 - 31 March 2026.

##### Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

##### Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Leasehold improvements | 3 years straight line
Fixtures and fittings | 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

##### Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Non-financial assets
At each balance sheet date, the Company reviews its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.
If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
Where it is not possible to estimate the recoverable amount of an individual asset, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

##### Investment property

Investment property is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at each reporting date with changes in fair value recognised in profit or loss. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.

##### Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

##### Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks

##### Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

#### 2. Employees

| Period from 01.10.2024 to 31.03.2026 |  | Year ended 30.09.2024
| Number |  | Number
Monthly average number of persons employed by the Company during the period, including directors | 0 |  | 0

#### 3. Tangible assets

| Leasehold improve- ments |  | Fixtures and fittings |  | Total
| £ |  | £ |  | £
Cost |  |  |  |  |
At 01 October 2024 | 10,257 |  | 2,395 |  | 12,652
Disposals | ( 10,257) |  | ( 2,395) |  | ( 12,652)
At 31 March 2026 | 0 |  | 0 |  | 0
Accumulated depreciation |  |  |  |  |
At 01 October 2024 | 10,257 |  | 2,395 |  | 12,652
Disposals | ( 10,257) |  | ( 2,395) |  | ( 12,652)
At 31 March 2026 | 0 |  | 0 |  | 0
Net book value |  |  |  |  |
At 31 March 2026 | 0 |  | 0 |  | 0
At 30 September 2024 | 0 |  | 0 |  | 0

#### 4. Investment property

| Investment property
| £
Valuation |
As at 01 October 2024 | 0
Additions | 180,000
As at 31 March 2026 | 180,000

#### 5. Fixed asset investments

Investments in subsidiaries

| 31.03.2026
| £
Cost |
At 01 October 2024 | 0
Additions | 800,000
At 31 March 2026 | 800,000
Carrying value at 31 March 2026 | 800,000
Carrying value at 30 September 2024 | 0

#### 6. Debtors

| 31.03.2026 |  | 30.09.2024
| £ |  | £
Trade debtors | 390 |  | 0
Other debtors | 609 |  | 0
| 999 |  | 0

#### 7. Creditors: amounts falling due within one year

| 31.03.2026 |  | 30.09.2024
| £ |  | £
Bank loans | 41,683 |  | 0
Amounts owed to Group undertakings | 38,000 |  | 0
Taxation and social security | 10,446 |  | 0
Other creditors | 38,379 |  | 0
| 128,508 |  | 0

Bank loans of £41,683 (2024: £nil) are secured by charges over certain assets of the company.

#### 8. Creditors: amounts falling due after more than one year

| 31.03.2026 |  | 30.09.2024
| £ |  | £
Bank loans | 851,814 |  | 0

Bank of Scotland holds a floating charge over all the property and undertakings of the Company. The charge contains a negative pledge.

#### 9. Called-up share capital

| 31.03.2026 |  | 30.09.2024
| £ |  | £
Allotted, called-up and fully-paid |  |  |
100 Ordinary shares of £ 1.00 each (30.09.2024: 11 shares of £ 1.00 each) | 100 |  | 11

#### 10. Related party transactions

Transactions with entities in which the entity itself has a participating interest

| 31.03.2026 |  | 30.09.2024
| £ |  | £
Amounts owed to subsidiary | 38,000 |  | 0

The above loans are unsecured, interest-free and repayable on demand.

Transactions with the entity's directors

| 31.03.2026 |  | 30.09.2024
| £ |  | £
Amounts owed to key management personnel | 33,579 |  | 0

The above loans are unsecured, interest-free and repayable on demand.